Yüksek riskli prostat kanserinde robotik ve açık radikal prostatektominin erken-dönem erektil fonksiyon sonuçlarının karşılaştırılması

AMAÇ: Robot-yardımlı (RYRP) ve retropubik (RRP) radikal prostatektominin fonksiyonel sonuçlarını karşılaştıran çok sayıda çalışma olmasına rağmen, yüksek-riskli hasta grubu gibi seçilmiş bir hasta grubunda karşılaştıran çalışma sayısı kısıtlıdır. Bu çalışmada, yüksek-riskli prostat kanserli (PK) hastalarda bu iki yöntemin ereksiyon sonuçlarının karşılaştırılması amaçlandı. GEREÇ ve YÖNTEM: Yüksek-riskli PK nedeniyle RRP uygulanan 84 hasta ve RYRP uygulanan 60 hasta çalışmaya dahil edildi. Hastaların demografik verileri, perioperatif veriler, hastaya ve hastalığa özgü faktörler, preoperatif ve postoperatif 3. ay Uluslararası Erektil Fonksiyon İndeksi (IIEF) skorları, hasta dosyalarından retrospektif olarak kaydedildi. Çalışmanın birincil amacı, iki yöntem arasında erektil fonksiyondaki değişimin karşılaştırılmasıydı; ikincil amacı ise iki yöntem arasındaki perioperatif verilerin ve onkolojik sonuçların karşılaştırılmasıydı. İstatistiksel anlamlılık için 0,05’den küçük p değerleri kabul edildi BULGULAR: İki grubun demografik ve histopatolojik verileri benzerdi. İki grupta da postoperatif 3. ayda bakılan IIEF skorunda belirgin azalma mevcuttu (birinci grupta -10,42±2,72 ve ikinci grupta -9,82±1,86 puan, p=0,330). Bununla uyumlu şekilde her iki grupta da orta ve ileri düzeyde erektil disfonksiyonu olan hasta oranında artış mevcuttu ancak bu oranlar arasında anlamlı bir farklılık yoktu. Her iki grupta da hastaların yaklaşık yarısında potens korunmuştu. Ayrıca, operasyon süresi RRP lehine bulunurken (p=0,024), postoperatif kateterizasyon süresi ve tahmini kan kaybı, RYRP lehine bulundu (sırasıyla, p=0,019 ve p=0,036). SONUÇ: Radikal prostatektomi, yüksek-riskli PK hastalarında düşük komplikasyon oranları ve erken dönem kabul edilebilir potens oranlarıyla güvenle uygulanabilir. Açık ve robotik teknik arasında yüksek-riskli PK hastalarında erken dönem erektil fonksiyonların korunmasında önemli bir fark saptanmamıştır

Comparison of short-term erectile function results of robotic and open radical prostatectomy in high-risk prostate cancer

OBJECTIVE: The number of studies comparing the functional results of robot-assisted (RARP) and retropubic (RRP) radical prostatectomy, in a high-risk group of patients, is limited. In this study, we compared the erectile function results of these two methods in patients with high-risk prostate cancer (PCa). MATERIAL and METHODS: Eighty-four patients who underwent RRP and 60 patients who underwent RARP for high-risk PCa were included in this study. Demographic data, perioperative data, patient and disease specific factors, preoperative and postoperative 3rd month International Index of Erectile Function (IIEF) scores were recorded retrospectively from hospital registration system. The primary aim of the study was to compare the change in erectile function between two methods; the secondary aim was to compare the perioperative data and oncologic results between the two methods. P values less than 0.05 were accepted for statistical significance. RESULTS: Demographic and pathological data of the two groups were similar. There was a significant decrease in the IIEF score in the postoperative 3rd month in both groups (-10.42±2.72 in the first group and-9.82±1.86 in the second group, p=0.330). Consistent with this finding, there was an increase in the number of patients with intermediate and advanced erectile dysfunction in both groups, but there was no significant difference between these groups. In both groups, the potency was preserved in approximately half of the patients. In addition, the mean operation time was found in favor of RRP (p=0.024), while mean postoperative catheterization time and estimated blood loss were found in favor of RARP (p=0.019 and p=0.036, respectively). CONCLUSION: Radical prostatectomy can be performed safely in patients with high-risk PCa with low complication rates and acceptable early potency rates. There was no significant difference between the open and the robotic technique for the preservation of short-term erectile function.

Kaynakça

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424. [CrossRef]

2. Vickers AJ. Prostate Cancer Screening: Time to Question How to Optimize the Ratio of Benefits and Harms. Ann Intern Med 2017;167:509–10. [CrossRef]

3. Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2017;71:618–29. [CrossRef]

4. Gandaglia G, Bravi CA, Dell’Oglio P, Mazzone E, Fossati N, Scuderi S, et al. The Impact of Implementation of the European Association of Urology Guidelines Panel Recommendations on Reporting and Grading Complications on Perioperative Outcomes after Robot-assisted Radical Prostatectomy. Eur Urol 2018;74:4–7. [CrossRef]

5. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostatecancer survivors. N Engl J Med 2008;358:1250–61. [CrossRef]

6. Çayan S, Kendirci M, Yaman Ö, Aşçı R, Orhan I, Usta MF, et al. Prevalence of erectile dysfunction in men over 40 years of age in Turkey: Results from the Turkish Society of Andrology Male Sexual Health Study Group. Turk J Urol 2017;43:122–9. [CrossRef]

7. Johansson E, Steineck G, Holmberg L, Johansson JE, Nyberg T, Ruutu M, Bill-Axelson A. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol 2011;12:891–9. [CrossRef]

8. Yaxley JW, Coughlin GD, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet 2016;388:1057–66. [CrossRef]

9. Wallerstedt A, Tyritzis SI, Thorsteinsdottir T, Carlsson S, Stranne J, Gustafsson O, et al. Short-term results after robot-assisted laparoscopic radical prostatectomy compared to open radical prostatectomy. Eur Urol 2015;67:660–70. [CrossRef]

10. Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol 2005;173:1938–42. [CrossRef]

11. Ficarra V, Novara G, Fracalanza S, D’Elia C, Secco S, Iafrate M, et al. A prospective, non-randomized trial comparing robot-assisted laparoscopic and retropubic radical prostatectomy in one European institution. BJU Int 2009;104:534–9. [CrossRef]

12. Krambeck AE, DiMarco DS, Rangel LJ, Bergstralh EJ, Myers RP, Blute ML, Gettman MT. Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot-assisted techniques. BJU Int 2009;103:448–53. [CrossRef]

13. Çimen Hİ, Direk HC, Halis F, Köse O, Gökçe A, Sağlam HS. Radikal prostatektomi sonrası erektil fonksiyon açısından robotik cerrahi ile açık cerrahinin karşılaştırılması. Androl Bul 2018;20:35−38. [CrossRef]

14. Sooriakumaran P, Pini G, Nyberg T, Derogar M, Carlsson S, Stranne J, et al. Erectile Function and Oncologic Outcomes Following Open Retropubic and Robot-assisted Radical Prostatectomy: Results from the LAParoscopic Prostatectomy Robot Open Trial. Eur Urol 2018;73:618–27. [CrossRef]

15. Haglind E, Carlsson S, Stranne J, Wallerstedt A, Wilderang U, Thorsteinsdottir T, et al. Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial. Eur Urol 2015;68:216–25. [CrossRef]

16. Recabal P, Assel M, Musser JE, Caras RJ, Sjoberg DD, Coleman JA, et al. Erectile Function Recovery after Radical Prostatectomy in Men with High Risk Features. J Urol 2016;196:507–13. [CrossRef]

17. Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing:15-year outcome. BJU Int 2005;95:751–6. [CrossRef]

18. Lavery HJ, Nabizada-Pace F, Carlucci JR, Brajtbord JS, Samadi DB. Nervesparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious. Urol Oncol 2012;30:26–32. [CrossRef]

19. Abdollah F, Sun M, Suardi N, Gallina A, Bianchi M, Tutolo M, et al. Prediction of functional outcomes after nerve-sparing radical prostatectomy: results of conditional survival analyses. Eur Urol 2012;62:42–52. [CrossRef]

20. Loeb S, Smith ND, Roehl KA, Catalona WJ. Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer. Urology 2007;69:1170–5. [CrossRef]

21. Novara G, Ficarra V, D’Elia C, Secco S, De Gobbi A, Cavalleri S, Artibani W. Preoperative criteria to select patients for bilateral nerve-sparing roboticassisted radical prostatectomy. J Sex Med 2010;7:839–45. [CrossRef]

22. Jayram G, Decastro GJ, Large MC, Razmaria A, Zagaja GP, Shalhav AL, Brendler CB. Robotic radical prostatectomy in patients with high-risk disease: a review of short-term outcomes from a high-volume center. J Endourol 2011;25:455–7. [CrossRef]

23. Finkelstein J, Eckersberger E, Sadri H, Taneja SS, Lepor H, Djavan B. Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience. Rev Urol 2010;12:35– 43. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859140/

24. Rassweiler J, Hruza M, Teber D, Su LM. Laparoscopic and robotic assisted radical prostatectomy--critical analysis of the results. Eur Urol 2006;49:612–24. [CrossRef]

25. Descazeaud A, Peyromaure M, Zerbib M. Will robotic surgery become the gold standard for radical prostatectomy? Eur Urol 2007;51:9–11. [CrossRef]

26. Çimen Hİ, Sağlam HS. Robotik prostat cerrahisi ve cinsel fonksiyon. Androl Bull 2016;18:79–82. https://www.journalagent.com/androloji/ pdfs/AND_18_65_79_82.pdf

27. Graefen M, Haese A, Pichlmeier U, Hammerer PG, Noldus J, Butz K, et al. A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. J Urol 2001;165:857–63. [CrossRef]

28. Zorn KC, Gofrit ON, Steinberg GP, Taxy JB, Zagaja GP, Shalhav AL. Planned nerve preservation to reduce positive surgical margins during robot-assisted laparoscopic radical prostatectomy. J Endourol 2008;22:1303–9. [CrossRef]

29. Beyer B, Schlomm T, Tennstedt P, Boehm K, Adam M, Schiffmann J, et al. A feasible and time-efficient adaptation of NeuroSAFE for da Vinci robot-assisted radical prostatectomy. Eur Urol 2014;66:138–44. [CrossRef]

30. Rud E, Baco E, Klotz D, Rennesund K, Svindland A, Berge V, et al. Does preoperative magnetic resonance imaging reduce the rate of positive surgical margins at radical prostatectomy in a randomised clinical trial? Eur Urol 2015;68:487–96. [CrossRef]

Kaynak Göster